09:35 AM EDT, 10/17/2025 (MT Newswires) -- PharmaCorp Rx (PCRX.V) said Friday that it filed a final short form base shelf prospectus allowing the company to launch an offering of up to $100 million.

The company may offer common shares, preferred shares, warrants, debt securities, subscription receipts, units, or any combination thereof, during a 25-month period.

"With this framework now in place, we have the flexibility to efficiently access capital as we continue to pursue strategic acquisitions and expansion opportunities across Canada, many of which arise through our ongoing alliance with PharmaChoice Canada," executive chairman Alan Simpson said. "This positions us to accelerate our national growth strategy and strengthen our operations platform."

PharmaCorp's share price fell 4.2% to a near 52-week low of $0.46 on the TSX Venture Exchange Thursday.